Literature DB >> 9716592

Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene.

M Pinotti1, R Toso, R Redaelli, M Berrettini, G Marchetti, F Bernardi.   

Abstract

In three Italian patients, two point mutations and a short deletion were found in the intron 7 of factor VII gene, clustered in the donor splice site and located in the first of several repeats. The mutation 9726+5G-->A, the most frequent cause of symptomatic factor VII deficiency in Italy, as well as the deletion (9729del4) gave rise in expression studies to abnormally spliced transcripts, which were exclusively produced from the cryptic site in the second repeat. The insertion in the mature mRNA of the first intronic repeat caused (9726+5G-->A) a reading frameshift, abolishing most of the factor VII catalytic domain, or produced (9729del4), an altered factor with 11 additional residues, the activity of which was not detectable in the cell medium after mutagenesis and expression studies. Studies of factor VII ectopic mRNA from leukocytes and expression studies indicated that the deleted gene produced 30% of normally spliced transcript. Differently, the 9726+5G-->A mutation permitted a very low level (0.2% to 1%) of correct splicing to occur, which could be of great importance to prevent the onset, in the homozygous patients, of most of the life-threatening bleeding symptoms. The 9726+7A-->G mutation was found to be a rare and functionally silent polymorphism. These findings, which provide further evidence of the interplay of sequence and position in the 5' splice site selection, throw light on the heterogeneous molecular bases and clinical phenotypes of FVII deficiency. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716592

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.

Authors:  Thomas J Cramer; Kristin Anderson; Karanjia Navaz; Justin M Brown; Laurent O Mosnier; Annette von Drygalski
Journal:  Blood Cells Mol Dis       Date:  2015-11-10       Impact factor: 3.039

2.  Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.

Authors:  Paris Margaritis; Valder R Arruda; Majed Aljamali; Rodney M Camire; Alexander Schlachterman; Katherine A High
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  Intrinsic differences between authentic and cryptic 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

4.  Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency.

Authors:  Lara Rizzotto; Mirko Pinotti; Paolo Pinton; Rosario Rizzuto; Francesco Bernardi
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

5.  Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant.

Authors:  Nicola Cavallari; Dario Balestra; Alessio Branchini; Iva Maestri; Ampaiwan Chuamsunrit; Werasak Sasanakul; Guglielmo Mariani; Franco Pagani; Francesco Bernardi; Mirko Pinotti
Journal:  Biochim Biophys Acta       Date:  2012-03-09

6.  Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency.

Authors:  Paolo Ferraresi; Dario Balestra; Caroline Guittard; Delphine Buthiau; Brigitte Pan-Petesh; Iva Maestri; Roula Farah; Mirko Pinotti; Muriel Giansily-Blaizot
Journal:  Haematologica       Date:  2019-07-04       Impact factor: 9.941

Review 7.  Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.

Authors:  Francesco Bernardi; Guglielmo Mariani
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

8.  Factor VII mutant V154G models a zymogen-like form of factor VIIa.

Authors:  Raffaella Toso; Francesco Bernardi; Theresa Tidd; Mirko Pinotti; Rodney M Camire; Giovanna Marchetti; Katherine A High; Eleanor S Pollak
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

9.  An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice.

Authors:  D Balestra; A Faella; P Margaritis; N Cavallari; F Pagani; F Bernardi; V R Arruda; M Pinotti
Journal:  J Thromb Haemost       Date:  2014-02       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.